BRAINSTORM CELL THERAPEUTICS INC. — Operating Income by Fiscal Year
16 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/138fb863-92b7-43a2-9c90-8d396abc91d4/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-10.0M | 2025-01-01 – 2025-12-31 | evidence 0001104659-26-037927 |
| FY 2024 | $-11.7M | 2024-01-01 – 2024-12-31 | evidence 0001410578-25-000545 |
| FY 2023 | $-21.4M | 2023-01-01 – 2023-12-31 | evidence 0001410578-24-000385 |
| FY 2022 | $-24.8M | 2022-01-01 – 2022-12-31 | evidence 0001410578-23-000426 |
| FY 2021 | $-24.5M | 2021-01-01 – 2021-12-31 | evidence 0001410578-22-000554 |
| FY 2020 | $-31.7M | 2020-01-01 – 2020-12-31 | evidence 0001104659-21-011928 |
| FY 2019 | $-23.0M | 2019-01-01 – 2019-12-31 | evidence 0001104659-20-022244 |
| FY 2018 | $-14.1M | 2018-01-01 – 2018-12-31 | evidence 0001144204-19-017041 |
| FY 2017 | $-5.0M | 2017-01-01 – 2017-12-31 | evidence 0001144204-18-013470 |
| FY 2016 | $-5.1M | 2016-01-01 – 2016-12-31 | evidence 0001144204-17-017265 |
| FY 2015 | $-8.5M | 2015-01-01 – 2015-12-31 | evidence 0001144204-16-086932 |
| FY 2014 | $-7.4M | 2014-01-01 – 2014-12-31 | evidence 0001144204-16-086932 |
| FY 2013 | $-54.2M | 2000-09-23 – 2014-03-31 | evidence 0001144204-14-029919 |
| FY 2012 | $-48.3M | 2000-09-23 – 2013-03-31 | evidence 0001144204-13-027214 |
| FY 2011 | $44.7M | 2000-09-23 – 2012-03-31 | evidence 0001144204-12-028107 |
| FY 2010 | $2.4M | 2010-01-01 – 2010-12-31 | evidence 0001144204-12-015305 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).